{"ticker": {"uuid": "2aff8808-efc9-4911-a9ec-759571e47c7a", "symbol": "INBS", "name": "Intelligent Bio Solutions Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News", "summary": "This document appears to be a stub or placeholder from Intelligent Bio Solutions related to its stock options chain, quotes, and news. There is no substantive content provided beyond the title.", "url": "https://www.moomoo.com/stock/INBS-US/options-chain?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fhans%2Fstock%2F002798-SZ%2Fearnings%22%7D", "source_name": "Moomoo", "published_at": "2026-07-04T17:39:22", "published_display": "04 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS - Intelligent Bio Solutions Inc Revenue Breakdown", "summary": "This article provides a detailed financial overview of Intelligent Bio Solutions Inc (INBS), including its market capitalization, income, sales, and various financial ratios. It also lists key performance indicators such as EPS, sales growth, insider and institutional ownership, ", "url": "https://finviz.com/stock?t=INBS&ty=rv&ta=0&p=m", "source_name": "Finviz", "published_at": "2026-07-03T15:40:08", "published_display": "03 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Intelligent Bio Solutions Inc. \u2013 NASDAQ:INBS", "summary": "This article provides the enterprise value to forward EBIT for Intelligent Bio Solutions Inc. (NASDAQ: INBS). It is presented on a financial data page within the TradingView platform, showing only the \"Period\", \"Value\", \"Change\", and \"Change %\" categories without populating them.", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T16:12:50", "published_display": "29 Jun 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Intelligent Bio Solutions Inc. (INBS) stock, detailing analyst price targets, historical performance, and key financial metrics. It highlights that one analyst has a price target of $12.00, while the stock has seen a significant decrease over ", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T09:09:13", "published_display": "27 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Intelligent Bio Solutions Inc. \u2013 NASDAQ:INBS", "summary": "This article provides financial information for Intelligent Bio Solutions Inc. (NASDAQ: INBS) on TradingView, specifically focusing on its price-to-sales forward metric. It indicates that the market is currently closed with no trades. The core content is limited to presenting the", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:09:13", "published_display": "27 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. Actuals & Estimates (NASDAQ:INBS)", "summary": "This article provides comprehensive financial data, analyst estimates, and performance metrics for Intelligent Bio Solutions Inc. (NASDAQ:INBS). It details the company's current stock price, historical highs and lows, market capitalization, earnings, revenue, and future forecasts", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:40:08", "published_display": "26 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Intelligent Bio Solutions Inc (INBS), noting its current valuation score of 8.07, ranking 174 out of 388 in its industry. It highlights the company's P/E ratio of -0.19 and mentions that relevant data for P/B, P/S, and P/CF have not y", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T23:11:44", "published_display": "23 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Intelligent Bio Solutions Inc (INBS), noting its current price momentum score and suggesting it's suitable for range-bound swing trading as it trades between resistance at $2.50 and support at $1.94. The analysis includes various tech", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/technical", "source_name": "TradingKey", "published_at": "2026-06-22T11:39:33", "published_display": "22 Jun 2026 11:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Intelligent Bio Solutions Inc (INBS) stock performance, dividend history, and stock split events. It highlights that the company has not distributed any dividends over the past five years and details several merger-related stock splits with th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-19T09:09:36", "published_display": "19 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Institutional Confidence", "summary": "This article from TradingKey provides an overview of the institutional confidence in Intelligent Bio Solutions Inc (INBS). It details the company's stock information, including its market cap and recent price movements, and presents institutional shareholding data with significan", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:31", "published_display": "18 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Intelligent Bio Solutions Inc (INBS), detailing its regional revenue contributions. As of the latest update, the company has not yet disclosed relevant data for its business segments and certain financial periods. However, the existin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T03:10:46", "published_display": "18 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides a detailed breakdown of Intelligent Bio Solutions Inc (INBS) shareholder structure, including major individual shareholders, institutional holdings, and shareholder types. It lists key individual investors like Sakiris (Spiro Kevin) and Simeonidis (Harry) al", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T02:10:28", "published_display": "18 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Intelligent Bio Solutions Inc (INBS) currently lacks an earnings forecast score, contrasting with the Biotechnology & Medical Research industry average of 8.13. Analyst forecasts set an average price target of $12.00 for INBS, with both the highest and lowest predictions at this ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T08:09:55", "published_display": "17 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Intelligent Bio Solutions Inc (INBS) has a stable financial status with a current financial score of 6.73, ranking 223rd in the Biotechnology & Medical Research industry. The company reported a significant year-over-year revenue increase of 45.54% and a net profit increase of 12.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T08:09:55", "published_display": "17 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry", "summary": "Intelligent Bio Solutions Inc. announced the initiation of a clinical Interference Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. This study, which will enroll 75 healthy adults a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/INBS/pressreleases/2492474/intelligent-bio-solutions-initiates-clinical-study-supporting-fda-clearance-and-planned-us-market-entry/", "source_name": "The Globe and Mail", "published_at": "2026-06-16T21:10:17", "published_display": "16 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Study tests if everyday substances can skew fingerprint drug screens", "summary": "Intelligent Bio Solutions (INBS) has initiated an Interference Study for its Intelligent Fingerprinting Drug Screening System to detect codeine. This study, conducted with CenExel Clinical Research, will enroll 75 healthy adults to assess how common substances affect test accurac", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-initiates-clinical-study-supporting-fda-gcwej5moaqn7.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:10:17", "published_display": "16 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection", "summary": "Intelligent Bio Solutions (INBS) has initiated an Interference Study to support its FDA 510(k) submission for codeine detection using its Intelligent Fingerprinting Drug Screening System. The study will involve 75 healthy adults to assess the impact of common interferents, with r", "url": "https://www.tradingview.com/news/tradingview:f868241b2d5d3:0-intelligent-bio-solutions-launches-interference-study-to-support-fda-510-k-for-codeine-detection/", "source_name": "TradingView", "published_at": "2026-06-16T20:40:50", "published_display": "16 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Launches FDA Interference Study for Fingerprinting Drug Test System", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/intelligent-bio-solutions-launches-fda-130726063.html", "source_name": "MT Newswires", "published_at": "2026-06-16T13:07:26+00:00", "published_display": "16 Jun 2026 13:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System", "summary": "Intelligent Bio Solutions Inc. has launched an Interference Study for its Intelligent Fingerprinting Drug Screening System to validate its specificity for codeine detection. This study, involving 75 healthy adults, is a crucial part of the company's FDA 510(k) submission for U.S.", "url": "https://www.quiverquant.com/news/Intelligent+Bio+Solutions+Initiates+Interference+Study+to+Support+FDA+510(k)+Submission+for+Drug+Screening+System", "source_name": "Quiver Quantitative", "published_at": "2026-06-16T12:43:00", "published_display": "16 Jun 2026 12:43", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry", "summary": "Intelligent Bio Solutions (INBS) has commenced a clinical study as a crucial step towards obtaining FDA clearance. This initiative is designed to support the company's planned entry into the US market. The announcement was made via Reuters and Refinitiv.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_TUA8PGHX4:0-intelligent-bio-solutions-initiates-clinical-study-supporting-fda-clearance-and-planned-us-market-entry/", "source_name": "TradingView", "published_at": "2026-06-16T12:39:39", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Interference study backs Intelligent Bio (NASDAQ: INBS) U.S. codeine test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZGZyXzY0aGRCQURVQ0NnR1d4YjlRX1RfZnFkN29Wd3k5UUpMeXpwM3ZNV19lMkZ6Vm5LakRJNEZGamRuVi14dU1FdUxsUHhGRUtEeE9NWE1GVXROcV82N2xkUFBEclFhWWJlb1dqUkFvT3Z4Nm5GRUp6OUZzWEdyRjhNRDVyRW41S29xUm5oV0taWHZFaVpVNE9YUG9ib2dDb0IyWldnVWVxYTJKV1lHNENYY0lUODdlcmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings", "summary": "This article provides an overview of Intelligent Bio Solutions Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports. It highlights key financial performance metrics such as revenue growth, gross margin improvements, and progress on FDA cle", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/documents/", "source_name": "TradingView", "published_at": "2026-06-12T16:09:21", "published_display": "12 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership", "summary": "Intelligent Bio Solutions Inc. (INBS) saw its stock reverse early gains, trading 2% lower after announcing the first shipment of its Intelligent Fingerprinting Drug Screening Readers, manufactured under a partnership with Syrma Johari MedTech. These devices are being deployed acr", "url": "https://stocktwits.com/news-articles/markets/equity/why-did-inbs-stock-jump-in-pre-market-today/cZRyEM9RIG7", "source_name": "Stocktwits", "published_at": "2026-06-06T03:39:10", "published_display": "06 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18", "summary": "Intelligent Bio Solutions Inc. (INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company will participate in investor meetings and present on June 17th. INBS specializes in rapid, non-invasive fingerprint-based", "url": "https://www.marketscreener.com/news/intelligent-bio-solutions-to-participate-in-planet-microcap-las-vegas-conference-over-june-16-18-ce7f5ddcde8ff025", "source_name": "www.marketscreener.com", "published_at": "2026-06-04T12:39:06", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vegas microcap conference adds Intelligent Bio Solutions to lineup", "summary": "Intelligent Bio Solutions (Nasdaq: INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company is scheduled to present on June 17, 2026, and will host one-on-one investor meetings throughout the event. This partic", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-to-participate-in-planet-micro-cap-las-v9fflqbb0jz0.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:06", "published_display": "04 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions starts FDA study for fingerprint drug test", "summary": "Intelligent Bio Solutions Inc. (NASDAQ:INBS) has commenced a multi-site study for its Intelligent Fingerprinting Drug Screening System for codeine, aiming for FDA 510(k) clearance in the U.S. The study, conducted with CenExel Clinical Research, will assess the system's accuracy w", "url": "https://www.investing.com/news/company-news/intelligent-bio-solutions-starts-fda-study-for-fingerprint-drug-test-93CH-4722022", "source_name": "Investing.com", "published_at": "2026-06-02T12:55:14", "published_display": "02 Jun 2026 12:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent begins multi-site study to support FDA 510(k) for codeine screening", "summary": "Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study to support its FDA 510(k) submission for its Fingerprinting Drug Screening System for codeine. The study, conducted with CenExel, will evaluate the system's accuracy with typical workplace oper", "url": "https://www.tradingview.com/news/tradingview:8b4187622ea58:0-intelligent-begins-multi-site-study-to-support-fda-510-k-for-codeine-screening/", "source_name": "TradingView", "published_at": "2026-06-02T12:53:14", "published_display": "02 Jun 2026 12:53", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission", "summary": "Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. This study aims to support its FDA 510(k) submission for U.S. market clearance specifically for the opiate codeine. The company expects", "url": "https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/intelligent-bio-solutions-commences-multi-site-method-comparison-study-for-fda-510k-submission/2356861", "source_name": "The Manila Times", "published_at": "2026-06-02T12:48:14", "published_display": "02 Jun 2026 12:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study", "summary": "Intelligent Bio Solutions (INBS) has initiated a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System for codeine. This study supports its FDA 510(k) submission for U.S. market clearance, aiming to validate the system's accuracy and real-wor", "url": "https://www.stocktitan.net/sec-filings/INBS/8-k-intelligent-bio-solutions-inc-reports-material-event-b1d9270f2745.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:48:14", "published_display": "02 Jun 2026 12:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fingerprint drug test put in workers' hands in new U.S. study", "summary": "Intelligent Bio Solutions (Nasdaq: INBS) has initiated a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. The study, conducted with CenExel Clinical Research, ", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-commences-multi-site-method-comparison-y9dqkbsfd4qp.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:39:14", "published_display": "02 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live stock quotes and charts for Intelligent Bio Solutions Inc. (INBS), showing its current stock price and a recent decline. It highlights that there is currently no analyst rating or average price target for the company, and no recent earnings information ava", "url": "https://stockstotrade.com/quote/INBS/", "source_name": "StocksToTrade", "published_at": "2026-05-23T21:38:59", "published_display": "23 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year", "summary": "", "url": "https://finance.yahoo.com/news/intelligent-bio-solutions-reports-fiscal-123000582.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T12:30:00+00:00", "published_display": "13 May 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/intelligent-bio-solutions-initiates-validation-131500326.html", "source_name": "GlobeNewswire", "published_at": "2026-04-20T13:15:00+00:00", "published_display": "20 Apr 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Intelligent Bio Solutions Signs Multiple Financing Agreements", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVgyUGhaVlE2cXphdjhpWUlxWU0zN2R0Uy1hWHZTTE5fLVpLWVpmWDNlV3JnNjZNMGVHQnUwaHZ6c1A5TVFBNWh2R3VhaVVsWlA5STlnZ3c2Wi1VcU9iTTF6dkFYLWZDMjhQSk5tbGlKallnQmxvc2otUENGT0E3UUlyWHYzVkp3Q29MT2xLenZwbFRsMFg2ZkdNeXJXb1o3aVppSkowa0QwS3BTdUtpcmpyQUQtbGpkVkVnd05NVDM?oc=5", "source_name": "TradingView", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. Partners with Syrma Johari MedTech to Enhance Manufacturing Capabilities and Improve Cost Efficiency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNY1ktRDJzSFJmOTdZLXJDZGJvOFhoTEZDQnRkN0h5dVFON1dURENTMDhYUW1BWDZybDNHeUlYTHM3UGV2Mm1zRmpIQzluQjJ1NVc4eXRaSG1ubkUyVGMxNUZIM0dBQWFTZHlraEJsdmoyU1JRNjN4NkhQZ255bzdlX3NReWlYbVhKLS1lQVIzcjhxS29iMllRV1AyenVGTTZITlFWREhSU0pxS3VyZm1Bc0dNcE1zbW1NYzloMTh1TGZLbDFXNHFHaFVsdUU1MVZjR3MyMlBPeW41Q2sySUFyOU4wVG5UQWoycFVlYlpCcm5ndGU0dU1v?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS | Intelligent Bio Solutions Inc. Institutional Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE4zNU44NzQzcDd5NlpQMjE3b1gtZ1pheVluVzBValc5RlJiNlQ5dmxKRUZ4bU1QdEI2WTFaODJYYXNCR1UxeHZVV29sb0duOVhXV1h5TVlQdVlNV082a3U1OW1R?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-09-02T03:16:58+00:00", "published_display": "02 Sep 2025 03:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News", "summary": "This document appears to be a stub or placeholder from Intelligent Bio Solutions related to its stock options chain, quotes, and news. There is no substantive content provided beyond the title.", "url": "https://www.moomoo.com/stock/INBS-US/options-chain?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fhans%2Fstock%2F002798-SZ%2Fearnings%22%7D", "source_name": "Moomoo", "published_at": "2026-07-04T17:39:22", "published_display": "04 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS - Intelligent Bio Solutions Inc Revenue Breakdown", "summary": "This article provides a detailed financial overview of Intelligent Bio Solutions Inc (INBS), including its market capitalization, income, sales, and various financial ratios. It also lists key performance indicators such as EPS, sales growth, insider and institutional ownership, ", "url": "https://finviz.com/stock?t=INBS&ty=rv&ta=0&p=m", "source_name": "Finviz", "published_at": "2026-07-03T15:40:08", "published_display": "03 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Intelligent Bio Solutions Inc. \u2013 NASDAQ:INBS", "summary": "This article provides the enterprise value to forward EBIT for Intelligent Bio Solutions Inc. (NASDAQ: INBS). It is presented on a financial data page within the TradingView platform, showing only the \"Period\", \"Value\", \"Change\", and \"Change %\" categories without populating them.", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T16:12:50", "published_display": "29 Jun 2026 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Intelligent Bio Solutions Inc. (INBS) stock, detailing analyst price targets, historical performance, and key financial metrics. It highlights that one analyst has a price target of $12.00, while the stock has seen a significant decrease over ", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T09:09:13", "published_display": "27 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Intelligent Bio Solutions Inc. \u2013 NASDAQ:INBS", "summary": "This article provides financial information for Intelligent Bio Solutions Inc. (NASDAQ: INBS) on TradingView, specifically focusing on its price-to-sales forward metric. It indicates that the market is currently closed with no trades. The core content is limited to presenting the", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T02:09:13", "published_display": "27 Jun 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. Actuals & Estimates (NASDAQ:INBS)", "summary": "This article provides comprehensive financial data, analyst estimates, and performance metrics for Intelligent Bio Solutions Inc. (NASDAQ:INBS). It details the company's current stock price, historical highs and lows, market capitalization, earnings, revenue, and future forecasts", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:40:08", "published_display": "26 Jun 2026 21:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Intelligent Bio Solutions Inc (INBS), noting its current valuation score of 8.07, ranking 174 out of 388 in its industry. It highlights the company's P/E ratio of -0.19 and mentions that relevant data for P/B, P/S, and P/CF have not y", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-23T23:11:44", "published_display": "23 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Intelligent Bio Solutions Inc (INBS), noting its current price momentum score and suggesting it's suitable for range-bound swing trading as it trades between resistance at $2.50 and support at $1.94. The analysis includes various tech", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/technical", "source_name": "TradingKey", "published_at": "2026-06-22T11:39:33", "published_display": "22 Jun 2026 11:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Intelligent Bio Solutions Inc (INBS) stock performance, dividend history, and stock split events. It highlights that the company has not distributed any dividends over the past five years and details several merger-related stock splits with th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-19T09:09:36", "published_display": "19 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Institutional Confidence", "summary": "This article from TradingKey provides an overview of the institutional confidence in Intelligent Bio Solutions Inc (INBS). It details the company's stock information, including its market cap and recent price movements, and presents institutional shareholding data with significan", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T09:39:31", "published_display": "18 Jun 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for Intelligent Bio Solutions Inc (INBS), detailing its regional revenue contributions. As of the latest update, the company has not yet disclosed relevant data for its business segments and certain financial periods. However, the existin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T03:10:46", "published_display": "18 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides a detailed breakdown of Intelligent Bio Solutions Inc (INBS) shareholder structure, including major individual shareholders, institutional holdings, and shareholder types. It lists key individual investors like Sakiris (Spiro Kevin) and Simeonidis (Harry) al", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T02:10:28", "published_display": "18 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Intelligent Bio Solutions Inc (INBS) currently lacks an earnings forecast score, contrasting with the Biotechnology & Medical Research industry average of 8.13. Analyst forecasts set an average price target of $12.00 for INBS, with both the highest and lowest predictions at this ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T08:09:55", "published_display": "17 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Intelligent Bio Solutions Inc (INBS) has a stable financial status with a current financial score of 6.73, ranking 223rd in the Biotechnology & Medical Research industry. The company reported a significant year-over-year revenue increase of 45.54% and a net profit increase of 12.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-inbs/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T08:09:55", "published_display": "17 Jun 2026 08:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry", "summary": "Intelligent Bio Solutions Inc. announced the initiation of a clinical Interference Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. This study, which will enroll 75 healthy adults a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/INBS/pressreleases/2492474/intelligent-bio-solutions-initiates-clinical-study-supporting-fda-clearance-and-planned-us-market-entry/", "source_name": "The Globe and Mail", "published_at": "2026-06-16T21:10:17", "published_display": "16 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Study tests if everyday substances can skew fingerprint drug screens", "summary": "Intelligent Bio Solutions (INBS) has initiated an Interference Study for its Intelligent Fingerprinting Drug Screening System to detect codeine. This study, conducted with CenExel Clinical Research, will enroll 75 healthy adults to assess how common substances affect test accurac", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-initiates-clinical-study-supporting-fda-gcwej5moaqn7.html", "source_name": "Stock Titan", "published_at": "2026-06-16T21:10:17", "published_display": "16 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection", "summary": "Intelligent Bio Solutions (INBS) has initiated an Interference Study to support its FDA 510(k) submission for codeine detection using its Intelligent Fingerprinting Drug Screening System. The study will involve 75 healthy adults to assess the impact of common interferents, with r", "url": "https://www.tradingview.com/news/tradingview:f868241b2d5d3:0-intelligent-bio-solutions-launches-interference-study-to-support-fda-510-k-for-codeine-detection/", "source_name": "TradingView", "published_at": "2026-06-16T20:40:50", "published_display": "16 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Launches FDA Interference Study for Fingerprinting Drug Test System", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/intelligent-bio-solutions-launches-fda-130726063.html", "source_name": "MT Newswires", "published_at": "2026-06-16T13:07:26+00:00", "published_display": "16 Jun 2026 13:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System", "summary": "Intelligent Bio Solutions Inc. has launched an Interference Study for its Intelligent Fingerprinting Drug Screening System to validate its specificity for codeine detection. This study, involving 75 healthy adults, is a crucial part of the company's FDA 510(k) submission for U.S.", "url": "https://www.quiverquant.com/news/Intelligent+Bio+Solutions+Initiates+Interference+Study+to+Support+FDA+510(k)+Submission+for+Drug+Screening+System", "source_name": "Quiver Quantitative", "published_at": "2026-06-16T12:43:00", "published_display": "16 Jun 2026 12:43", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry", "summary": "Intelligent Bio Solutions (INBS) has commenced a clinical study as a crucial step towards obtaining FDA clearance. This initiative is designed to support the company's planned entry into the US market. The announcement was made via Reuters and Refinitiv.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_TUA8PGHX4:0-intelligent-bio-solutions-initiates-clinical-study-supporting-fda-clearance-and-planned-us-market-entry/", "source_name": "TradingView", "published_at": "2026-06-16T12:39:39", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Interference study backs Intelligent Bio (NASDAQ: INBS) U.S. codeine test", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZGZyXzY0aGRCQURVQ0NnR1d4YjlRX1RfZnFkN29Wd3k5UUpMeXpwM3ZNV19lMkZ6Vm5LakRJNEZGamRuVi14dU1FdUxsUHhGRUtEeE9NWE1GVXROcV82N2xkUFBEclFhWWJlb1dqUkFvT3Z4Nm5GRUp6OUZzWEdyRjhNRDVyRW41S29xUm5oV0taWHZFaVpVNE9YUG9ib2dDb0IyWldnVWVxYTJKV1lHNENYY0lUODdlcmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings", "summary": "This article provides an overview of Intelligent Bio Solutions Inc.'s financial disclosures and SEC filings, including quarterly and annual earnings reports. It highlights key financial performance metrics such as revenue growth, gross margin improvements, and progress on FDA cle", "url": "https://www.tradingview.com/symbols/NASDAQ-INBS/documents/", "source_name": "TradingView", "published_at": "2026-06-12T16:09:21", "published_display": "12 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership", "summary": "Intelligent Bio Solutions Inc. (INBS) saw its stock reverse early gains, trading 2% lower after announcing the first shipment of its Intelligent Fingerprinting Drug Screening Readers, manufactured under a partnership with Syrma Johari MedTech. These devices are being deployed acr", "url": "https://stocktwits.com/news-articles/markets/equity/why-did-inbs-stock-jump-in-pre-market-today/cZRyEM9RIG7", "source_name": "Stocktwits", "published_at": "2026-06-06T03:39:10", "published_display": "06 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18", "summary": "Intelligent Bio Solutions Inc. (INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company will participate in investor meetings and present on June 17th. INBS specializes in rapid, non-invasive fingerprint-based", "url": "https://www.marketscreener.com/news/intelligent-bio-solutions-to-participate-in-planet-microcap-las-vegas-conference-over-june-16-18-ce7f5ddcde8ff025", "source_name": "www.marketscreener.com", "published_at": "2026-06-04T12:39:06", "published_display": "04 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vegas microcap conference adds Intelligent Bio Solutions to lineup", "summary": "Intelligent Bio Solutions (Nasdaq: INBS) announced its management team will attend the Planet MicroCap Conference in Las Vegas from June 16-18, 2026. The company is scheduled to present on June 17, 2026, and will host one-on-one investor meetings throughout the event. This partic", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-to-participate-in-planet-micro-cap-las-v9fflqbb0jz0.html", "source_name": "Stock Titan", "published_at": "2026-06-04T12:39:06", "published_display": "04 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions starts FDA study for fingerprint drug test", "summary": "Intelligent Bio Solutions Inc. (NASDAQ:INBS) has commenced a multi-site study for its Intelligent Fingerprinting Drug Screening System for codeine, aiming for FDA 510(k) clearance in the U.S. The study, conducted with CenExel Clinical Research, will assess the system's accuracy w", "url": "https://www.investing.com/news/company-news/intelligent-bio-solutions-starts-fda-study-for-fingerprint-drug-test-93CH-4722022", "source_name": "Investing.com", "published_at": "2026-06-02T12:55:14", "published_display": "02 Jun 2026 12:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent begins multi-site study to support FDA 510(k) for codeine screening", "summary": "Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study to support its FDA 510(k) submission for its Fingerprinting Drug Screening System for codeine. The study, conducted with CenExel, will evaluate the system's accuracy with typical workplace oper", "url": "https://www.tradingview.com/news/tradingview:8b4187622ea58:0-intelligent-begins-multi-site-study-to-support-fda-510-k-for-codeine-screening/", "source_name": "TradingView", "published_at": "2026-06-02T12:53:14", "published_display": "02 Jun 2026 12:53", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission", "summary": "Intelligent Bio Solutions Inc. (INBS) has started a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. This study aims to support its FDA 510(k) submission for U.S. market clearance specifically for the opiate codeine. The company expects", "url": "https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/intelligent-bio-solutions-commences-multi-site-method-comparison-study-for-fda-510k-submission/2356861", "source_name": "The Manila Times", "published_at": "2026-06-02T12:48:14", "published_display": "02 Jun 2026 12:48", "sentiment": "positive", "sentiment_pct": 70, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study", "summary": "Intelligent Bio Solutions (INBS) has initiated a multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System for codeine. This study supports its FDA 510(k) submission for U.S. market clearance, aiming to validate the system's accuracy and real-wor", "url": "https://www.stocktitan.net/sec-filings/INBS/8-k-intelligent-bio-solutions-inc-reports-material-event-b1d9270f2745.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:48:14", "published_display": "02 Jun 2026 12:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fingerprint drug test put in workers' hands in new U.S. study", "summary": "Intelligent Bio Solutions (Nasdaq: INBS) has initiated a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. clearance of its Intelligent Fingerprinting Drug Screening System for codeine detection. The study, conducted with CenExel Clinical Research, ", "url": "https://www.stocktitan.net/news/INBS/intelligent-bio-solutions-commences-multi-site-method-comparison-y9dqkbsfd4qp.html", "source_name": "Stock Titan", "published_at": "2026-06-02T12:39:14", "published_display": "02 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live stock quotes and charts for Intelligent Bio Solutions Inc. (INBS), showing its current stock price and a recent decline. It highlights that there is currently no analyst rating or average price target for the company, and no recent earnings information ava", "url": "https://stockstotrade.com/quote/INBS/", "source_name": "StocksToTrade", "published_at": "2026-05-23T21:38:59", "published_display": "23 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year", "summary": "", "url": "https://finance.yahoo.com/news/intelligent-bio-solutions-reports-fiscal-123000582.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T12:30:00+00:00", "published_display": "13 May 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/intelligent-bio-solutions-initiates-validation-131500326.html", "source_name": "GlobeNewswire", "published_at": "2026-04-20T13:15:00+00:00", "published_display": "20 Apr 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Signs Multiple Financing Agreements", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVgyUGhaVlE2cXphdjhpWUlxWU0zN2R0Uy1hWHZTTE5fLVpLWVpmWDNlV3JnNjZNMGVHQnUwaHZ6c1A5TVFBNWh2R3VhaVVsWlA5STlnZ3c2Wi1VcU9iTTF6dkFYLWZDMjhQSk5tbGlKallnQmxvc2otUENGT0E3UUlyWHYzVkp3Q29MT2xLenZwbFRsMFg2ZkdNeXJXb1o3aVppSkowa0QwS3BTdUtpcmpyQUQtbGpkVkVnd05NVDM?oc=5", "source_name": "TradingView", "published_at": "2026-01-02T08:00:00+00:00", "published_display": "02 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intelligent Bio Solutions Inc. Partners with Syrma Johari MedTech to Enhance Manufacturing Capabilities and Improve Cost Efficiency", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNY1ktRDJzSFJmOTdZLXJDZGJvOFhoTEZDQnRkN0h5dVFON1dURENTMDhYUW1BWDZybDNHeUlYTHM3UGV2Mm1zRmpIQzluQjJ1NVc4eXRaSG1ubkUyVGMxNUZIM0dBQWFTZHlraEJsdmoyU1JRNjN4NkhQZ255bzdlX3NReWlYbVhKLS1lQVIzcjhxS29iMllRV1AyenVGTTZITlFWREhSU0pxS3VyZm1Bc0dNcE1zbW1NYzloMTh1TGZLbDFXNHFHaFVsdUU1MVZjR3MyMlBPeW41Q2sySUFyOU4wVG5UQWoycFVlYlpCcm5ndGU0dU1v?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-12-31T08:00:00+00:00", "published_display": "31 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INBS | Intelligent Bio Solutions Inc. Institutional Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE4zNU44NzQzcDd5NlpQMjE3b1gtZ1pheVluVzBValc5RlJiNlQ5dmxKRUZ4bU1QdEI2WTFaODJYYXNCR1UxeHZVV29sb0duOVhXV1h5TVlQdVlNV082a3U1OW1R?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-09-02T03:16:58+00:00", "published_display": "02 Sep 2025 03:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 87, "total_relevant": 47, "sentiment_summary": {"positive": 15, "negative": 4, "neutral": 28, "score": 54, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 8.94, "count": 19}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 2.16, "latest_week": "2026-07-10", "one_week_move": -3.6, "four_week_move": -10.0, "twelve_week_move": -18.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.313512, "market_dynamics_buy_signal": false, "relative_strength": -77.206325, "fair_value_gap": -93.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 36.1963, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.6% over one week, -10.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "TradingView", "count": 9}, {"label": "TradingKey", "count": 8}, {"label": "Stock Titan", "count": 5}, {"label": "Quiver Quantitative", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "GlobeNewswire", "count": 2}, {"label": "Moomoo", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 36}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 19}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "36", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.6% over one week, -10.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News"}], "updated_at": "2026-07-17T06:47:26.175207+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}